Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
5.64
-0.38 (-6.40%)
At close: Apr 28, 2026, 4:00 PM EDT
5.62
-0.02 (-0.33%)
After-hours: Apr 28, 2026, 4:07 PM EDT
Kalaris Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 15.4 | 6.69 | 1.76 | 2.24 |
| Research & Development | 30.75 | 45.04 | 11.71 | 11.76 |
| Operating Expenses | 46.15 | 51.73 | 13.46 | 14.01 |
| Operating Income | -46.15 | -51.73 | -13.46 | -14.01 |
| Interest Expense | -1.63 | -40.72 | -1.58 | -1.03 |
| Other Non Operating Income (Expenses) | 4.34 | 23.28 | 0.34 | 0.75 |
| EBT Excluding Unusual Items | -43.44 | -69.17 | -14.7 | -14.29 |
| Other Unusual Items | - | - | - | -1.2 |
| Pretax Income | -43.44 | -69.17 | -14.7 | -15.49 |
| Net Income | -43.44 | -69.17 | -14.7 | -15.49 |
| Net Income to Common | -43.44 | -69.17 | -14.7 | -15.49 |
| Shares Outstanding (Basic) | 15 | 1 | 6 | 4 |
| Shares Outstanding (Diluted) | 15 | 1 | 6 | 4 |
| Shares Change (YoY) | 1042.87% | -77.99% | 36.56% | - |
| EPS (Basic) | -2.85 | -51.77 | -2.42 | -3.48 |
| EPS (Diluted) | -2.85 | -51.77 | -2.42 | -3.48 |
| Free Cash Flow | -38.57 | -20.67 | -14.13 | -9.78 |
| Free Cash Flow Per Share | -2.53 | -15.47 | -2.33 | -2.20 |
| EBITDA | -46.14 | - | - | - |
| D&A For EBITDA | 0.01 | - | - | - |
| EBIT | -46.15 | -51.73 | -13.46 | -14.01 |
Source: S&P Capital IQ. Standard template.
Financial Sources.